Vanderbilt University Medical Center Is Pacesetter for National Aspirin Study
May 21, 2021
May 21, 2021
NASHVILLE, Tennessee, May 21 (TNSJou) -- Vanderbilt University Medical Center issued the following news:
By Paul Govern
According to an innovative large-scale clinical trial reported recently in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.
Amo . . .
By Paul Govern
According to an innovative large-scale clinical trial reported recently in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.
Amo . . .